Clinical use of bone-targeting radiopharmaceuticals with focus on alpha-emitters

doi:10.4329/wjr.v6.i7.480

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 6, Issue 7

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4991)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

338

WORD

348

HTML

2717

Figures (1-1)

128

Tables (1-1)

137

Sum=3668

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

801

Download

522

Sum=1323

Jul 28, 2014 (publication date) through Apr 15, 2024

Times Cited of This Article

Times Cited (15)

Journal Information of This Article

Publication Name

World Journal of Radiology

ISSN

1949-8470

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Radiol. Jul 28, 2014; 6(7): 480-485
Published online Jul 28, 2014. doi: 10.4329/wjr.v6.i7.480

Table 1 Physical characteristics of ⁸⁹Strontium, ¹⁵³Samarium and ²²³Radium

Radionuclide	Half-life	Maximum energy (MeV)	Mean energy (MeV)	Maximum range	y-Emission (keV)
⁸⁹Sr	50.5 d	1.4 (β)	0.583 (β)	7 mm	None
¹⁵³Sm	1.9 d	0.81 (β)	0.229 (β)	4 mm	103
²²³Ra	11.4 d	5.78 (α) average	-	< 10 μm	154

Citation: Wieder HA, Lassmann M, Allen-Auerbach MS, Czernin J, Herrmann K. Clinical use of bone-targeting radiopharmaceuticals with focus on alpha-emitters. World J Radiol 2014; 6(7): 480-485
URL: https://www.wjgnet.com/1949-8470/full/v6/i7/480.htm
DOI: https://dx.doi.org/10.4329/wjr.v6.i7.480